SMSLIFEPharmaceuticals
SMS Lifesciences India Ltd — Cash Flow Statement
₹1258.80
+0.00%
SMS Lifesciences India Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Investing Cash Flow | -15.00 Cr | -18.45 Cr | -31.29 Cr | -7.14 Cr | — |
| Net Other Investing Changes | -0.08 Cr | -0.12 Cr | 0.23 Cr | 0.38 Cr | — |
| Interest Received Cfi | 0.06 Cr | 0.08 Cr | 0.20 Cr | 0.21 Cr | — |
| Net Investment Purchase And Sale | 0.00 | 2.33 Cr | 11.08 Cr | 33.79 Cr | — |
| Sale Of Investment | 0.00 | 2.33 Cr | 11.20 Cr | 33.79 Cr | — |
| Net PPE Purchase And Sale | -14.98 Cr | -20.74 Cr | -42.80 Cr | -41.52 Cr | — |
| Sale Of PPE | 0.37 Cr | 0.12 Cr | 5.75 Cr | 9.64 Cr | — |
| Purchase Of PPE | -15.35 Cr | -20.87 Cr | -48.55 Cr | -51.15 Cr | — |
| Operating Cash Flow | 34.05 Cr | 24.31 Cr | 14.70 Cr | -11.24 Cr | — |
| Taxes Refund Paid | -8.50 Cr | -3.00 Cr | -3.26 Cr | -7.71 Cr | — |
| Change In Working Capital | -8.36 Cr | -4.03 Cr | -12.15 Cr | -37.62 Cr | — |
| Change In Other Current Liabilities | 47.20 Cr | 36.52 Cr | 37.13 Cr | -2.54 Cr | — |
| Change In Other Current Assets | -39.90 Cr | -39.72 Cr | -16.85 Cr | -28.79 Cr | — |
| Change In Payable | -5.63 Cr | -0.22 Cr | -18.12 Cr | 17.36 Cr | — |
| Change In Prepaid Assets | -1.35 Cr | -0.29 Cr | -1.29 Cr | 0.44 Cr | — |
| Change In Inventory | 13.81 Cr | 5.02 Cr | -0.28 Cr | -24.20 Cr | — |
| Change In Receivables | -22.50 Cr | -5.34 Cr | -12.74 Cr | 0.11 Cr | — |
| Other Non Cash Items | 4.17 Cr | 6.14 Cr | 3.62 Cr | 3.34 Cr | — |
| Provisionand Write Offof Assets | 5.06 Cr | 0.05 Cr | 0.51 Cr | 0.21 Cr | — |
| Depreciation And Amortization | 15.00 Cr | 14.94 Cr | 10.79 Cr | 10.01 Cr | — |
| Depreciation | 15.00 Cr | 14.94 Cr | 10.75 Cr | 9.97 Cr | — |
| Pension And Employee Benefit Expense | 0.53 Cr | 0.36 Cr | 0.94 Cr | 0.58 Cr | — |
| Gain Loss On Investment Securities | -0.03 Cr | 8000.00 | 12000.00 | -0.09 Cr | — |
| Net Income From Continuing Operations | 26.19 Cr | 9.85 Cr | 14.24 Cr | 20.04 Cr | — |
| Free Cash Flow | 18.71 Cr | 3.44 Cr | -33.86 Cr | -62.39 Cr | — |
| Repayment Of Debt | -17.80 Cr | -17.62 Cr | -11.44 Cr | -7.31 Cr | — |
| Issuance Of Debt | 4.06 Cr | 16.65 Cr | 32.78 Cr | 20.36 Cr | — |
| Capital Expenditure | -15.35 Cr | -20.87 Cr | -48.55 Cr | -51.15 Cr | — |
| End Cash Position | 0.50 Cr | 0.57 Cr | 1.28 Cr | 0.99 Cr | — |
| Beginning Cash Position | 0.57 Cr | 1.28 Cr | 0.99 Cr | 8.54 Cr | — |
| Changes In Cash | -0.07 Cr | -0.71 Cr | 0.29 Cr | -7.55 Cr | — |
| Financing Cash Flow | -19.12 Cr | -6.56 Cr | 16.89 Cr | 10.83 Cr | — |
| Interest Paid Cff | -4.31 Cr | -6.29 Cr | -3.53 Cr | -3.54 Cr | — |
| Cash Dividends Paid | -0.45 Cr | -0.45 Cr | -0.45 Cr | — | — |
| Net Issuance Payments Of Debt | -13.74 Cr | -0.98 Cr | 21.35 Cr | 13.04 Cr | — |
| Net Short Term Debt Issuance | 3.70 Cr | 16.65 Cr | 2.98 Cr | 8.66 Cr | — |
| Short Term Debt Issuance | 3.70 Cr | 16.65 Cr | 2.98 Cr | 8.66 Cr | — |
| Net Long Term Debt Issuance | -17.45 Cr | -17.62 Cr | 18.37 Cr | 4.38 Cr | — |
| Long Term Debt Payments | -17.80 Cr | -17.62 Cr | -11.44 Cr | -7.31 Cr | — |
| Long Term Debt Issuance | 0.35 Cr | 0.00 | 29.81 Cr | 11.69 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | 1000.00 | -1000.00 | — |
| Net Other Financing Charges | — | 1000.00 | — | — | -1000.00 |
| Amortization Cash Flow | — | 0.03 Cr | 0.04 Cr | 0.04 Cr | 0.04 Cr |
| Purchase Of Investment | — | — | -0.12 Cr | 0.00 | -2.02 Cr |
| Short Term Debt Payments | — | — | — | 0.00 | -0.76 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on SMS Lifesciences India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.